DL-Isoserine

DL-Isoserine is a DL (racemic) amino acid with the isomeric side chain of serine, featuring a primary amino group and a carboxylic acid (or, depending on form, a carboxylate/ester) alongside a hydroxymethyl functional group that can participate in hydrogen bonding and derivatization chemistry. The molecule bears a stereogenic center at the α-carbon, giving rise to two enantiomers (L- and D-isoserine) that are often treated as a racemate for intermediate preparation and method development. As an amino alcohol analog, DL-Isoserine can undergo standard amino acid transformations including N-protection, esterification, oxidation/reduction of the hydroxyl-bearing side chain, and conversion to activated derivatives for coupling reactions. The presence of both amine and hydroxyl groups enables orthogonal protection strategies and downstream synthesis of chiral or functionalized amino acid derivatives used in peptide science and fine chemical manufacturing.

1. Peptide Coupling Research

DL-Isoserine supports peptide building-block development in research settings where amino acid coupling chemistry is evaluated or where isoserine-containing sequences are used as structural probes. The amino and carboxyl functionalities enable conversion to N-protected forms and activated carboxyl derivatives suitable for amide bond formation, while the side-chain hydroxyl group can be protected to control chemoselectivity during sequential couplings. Racemic composition can be leveraged for method screening, generating mixed stereochemical outcomes that are useful for analytical method development and coupling-condition optimization. Downstream, DL-Isoserine-derived protected intermediates can be incorporated into peptide analogs and short peptidomimetics to study backbone/side-chain effects on conformation and reactivity.

2. Amino Acid Derivatization

DL-Isoserine is used as a starting amino acid for amino acid derivatization workflows that target side-chain functional group transformation and improved handling as protected intermediates. The hydroxymethyl substituent enables derivatization to ethers, esters, or carbonyl-containing derivatives, while the amino group can be protected to permit selective side-chain chemistry under orthogonal conditions. Racemate handling can simplify supply for process chemistry intermediate preparation where enantiopure material is not required for the immediate downstream step, such as generating bulk quantities of functionalized derivatives for library synthesis. Resulting products include substituted isoserine analogs, N-protected amino acid derivatives, and activated intermediates that can be carried forward into peptide construction, chemical biology probes, or further synthetic elaboration.

3. Chiral Resolution Development

DL-Isoserine is applicable to chiral synthesis workflows that require a racemic amino acid feedstock for resolution, stereoselective conversion, or enantiomer-enriched intermediate production. The α-stereocenter and the side-chain hydroxyl provide multiple interaction sites for forming diastereomeric derivatives with chiral acids, chiral auxiliaries, or selective enzymatic transformations. The compound's amino acid functionality supports conversion into protected or activated derivatives that can be subjected to stereochemical enrichment strategies while maintaining the carbon skeleton for downstream coupling. Enantiomer-enriched isoserine derivatives generated from the racemate can then serve as chiral amino acid intermediates for stereodefined peptide analogs and stereochemically controlled SAR studies.

4. Chemical Biology Probes

DL-Isoserine can be employed in chemical biology research as a scaffold for amino acid-based probes that rely on side-chain hydroxyl chemistry and amino acid recognition motifs. The amino acid backbone enables incorporation into labeled or conjugatable constructs through N-protection and subsequent coupling to electrophiles or activated linkers, while the hydroxymethyl group can serve as a handle for derivatization to fluorescent tags, affinity reagents, or clickable moieties. Racemic material may be used for initial probe screening, where stereochemical effects can be mapped by comparing later resolved or enantiopure analogs. Downstream probe generation benefits from the ability to form stable amide linkages and to tune polarity through side-chain functional group modification.

5. Pharmaceutical Intermediate Preparation

DL-Isoserine is suitable for pharmaceutical intermediate preparation in fine chemical synthesis routes where amino acid-derived functional groups must be introduced with controlled protection and activation states. The molecule can be transformed into N-protected amino acid derivatives and carboxyl-activated intermediates that participate in peptide-like bond formation or in the synthesis of amino acid analogs used as process intermediates. The hydroxymethyl side chain can be protected during coupling steps and later deprotected or oxidized/reduced to access additional functional handles, supporting manufacturing route design that minimizes protecting-group reshuffling. Racemic use aligns with industrial practice for bulk intermediate generation when downstream steps either tolerate stereochemistry or include an explicit stereochemical enrichment stage.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment